Mawer Investment Management Ltd. Buys 20,438 Shares of Elevance Health, Inc. $ELV

Mawer Investment Management Ltd. raised its stake in Elevance Health, Inc. (NYSE:ELV) by 10.9% during the fourth quarter, HoldingsChannel.com reports. The fund owned 207,095 shares of the company’s stock after purchasing an additional 20,438 shares during the quarter. Mawer Investment Management Ltd.’s holdings in Elevance Health were worth $72,597,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. GW Henssler & Associates Ltd. bought a new stake in Elevance Health in the 4th quarter valued at $217,000. New Mexico Educational Retirement Board increased its holdings in Elevance Health by 3.9% in the 4th quarter. New Mexico Educational Retirement Board now owns 10,646 shares of the company’s stock valued at $3,732,000 after acquiring an additional 400 shares during the last quarter. Easterly Investment Partners LLC increased its holdings in Elevance Health by 59.0% in the 4th quarter. Easterly Investment Partners LLC now owns 43,110 shares of the company’s stock valued at $15,112,000 after acquiring an additional 15,998 shares during the last quarter. Thompson Siegel & Walmsley LLC increased its holdings in Elevance Health by 7.5% in the 4th quarter. Thompson Siegel & Walmsley LLC now owns 21,230 shares of the company’s stock valued at $7,442,000 after acquiring an additional 1,475 shares during the last quarter. Finally, Florida Financial Advisors LLC bought a new stake in Elevance Health in the 4th quarter valued at $210,000. 89.24% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

ELV has been the topic of a number of research reports. Robert W. Baird lifted their price target on shares of Elevance Health from $317.00 to $331.00 and gave the company a “neutral” rating in a report on Thursday, April 23rd. Royal Bank Of Canada downgraded shares of Elevance Health from an “outperform” rating to a “sector perform” rating and set a $358.00 price target on the stock. in a report on Tuesday, February 3rd. Barclays increased their price objective on shares of Elevance Health from $408.00 to $480.00 and gave the company an “overweight” rating in a research report on Tuesday, May 26th. JPMorgan Chase & Co. increased their price objective on shares of Elevance Health from $397.00 to $411.00 and gave the company an “overweight” rating in a research report on Tuesday, April 28th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Elevance Health from a “hold” rating to a “buy” rating and increased their price objective for the company from $363.00 to $498.00 in a research report on Wednesday, May 20th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, Elevance Health presently has a consensus rating of “Moderate Buy” and an average target price of $407.05.

Elevance Health Trading Up 2.4%

Shares of ELV opened at $402.69 on Tuesday. Elevance Health, Inc. has a twelve month low of $273.71 and a twelve month high of $408.00. The company has a market cap of $87.45 billion, a P/E ratio of 17.13, a P/E/G ratio of 2.22 and a beta of 0.66. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 0.70. The company’s fifty day simple moving average is $345.97 and its 200-day simple moving average is $339.77.

Elevance Health (NYSE:ELV) last announced its earnings results on Wednesday, April 22nd. The company reported $12.58 earnings per share for the quarter, beating the consensus estimate of $10.74 by $1.84. Elevance Health had a net margin of 2.62% and a return on equity of 15.58%. The business had revenue of $49.49 billion for the quarter, compared to the consensus estimate of $48.21 billion. During the same quarter in the prior year, the firm posted $11.97 earnings per share. The business’s revenue for the quarter was up 1.5% on a year-over-year basis. Elevance Health has set its FY 2026 guidance at 19.850- EPS. As a group, analysts expect that Elevance Health, Inc. will post 26.94 EPS for the current year.

Elevance Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Wednesday, June 10th will be paid a $1.72 dividend. The ex-dividend date of this dividend is Wednesday, June 10th. This represents a $6.88 annualized dividend and a dividend yield of 1.7%. Elevance Health’s dividend payout ratio is currently 29.26%.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.